ENVOY MEDICAL INC (COCH) Stock News

NASDAQ:COCH - Nasdaq - US29415V1098 - Common Stock - Currency: USD

1.555 +0.02 (+1.63%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

COCH Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: Yahoo Finance

Envoy Medical Draws Final $5 Million From GAT Funding

2 months ago - By: Virtual Investor Conferences - Mentions: NIKA TIVC ADIA STSS ...

Life Sciences Investor Forum: Now Available for Online Viewing

2 months ago - By: Virtual Investor Conferences

Envoy Medical to Present at the Life Sciences Virtual Investor Forum June 12th

2 months ago - By: Virtual Investor Conferences - Mentions: NIKA TIVC ADIA STSS ...

Life Sciences Investor Forum Agenda Announced for June 11th-12th

3 months ago - By: Benzinga - Mentions: WORX XNCR MTNB VYGR ...

12 Health Care Stocks Moving In Friday's After-Market Session

8 months ago - By: Envoy Medical, Inc

Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss

8 months ago - By: Envoy Medical, Inc

Envoy Medical Receives Additional Patent Protection for its Innovative Approach to Hearing Loss

8 months ago - By: Benzinga - Mentions: PBM BRTX BLUE CAPR ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session

9 months ago - By: Envoy Medical, Inc

Envoy Medical Reports Third Quarter 2024 Results and Other Exciting Events

9 months ago - By: Envoy Medical, Inc

Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication

9 months ago - By: Envoy Medical, Inc

Envoy Medical’s Fully Implanted Acclaim® Cochlear Implant Highlighted in Peer-Reviewed Publication

9 months ago - By: Envoy Medical, Inc

Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System

9 months ago - By: Envoy Medical, Inc

Envoy Medical Receives Another European Patent for its Modular Cochlear Implant System

9 months ago - By: Envoy Medical, Inc

Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device

9 months ago - By: Envoy Medical, Inc

Envoy Medical Receives FDA Approval To Initiate Pivotal Clinical Study for Breakthrough Hearing Device

10 months ago - By: Envoy Medical, Inc

Key Advocates Urge CMS to Clarify that Fully Implanted Active Middle Ear Hearing Devices are Prosthetic Devices for Purposes of Medicare Coverage

10 months ago - By: Envoy Medical, Inc

Envoy Medical to Present at the LD Micro Main Event XVII

10 months ago - By: Envoy Medical, Inc

Envoy Medical to Present at the LD Micro Main Event XVII

10 months ago - By: Envoy Medical, Inc

American Medical Association Approves Groundbreaking New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Opening New Opportunities for Envoy Medical’s Esteem® Device

11 months ago - By: Envoy Medical, Inc

Envoy Medical Celebrates First Anniversary Trading as a Public Company under COCH on Nasdaq Capital Market

11 months ago - By: Envoy Medical, Inc

Envoy Medical Celebrates First Anniversary Trading as a Public Company under COCH on Nasdaq Capital Market

a year ago - By: Envoy Medical, Inc

Major Envoy Medical Investor Glen Taylor Discusses How Apple’s AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company